Accuray is a medical device company that develops, manufactures and sells radiation therapy systems designed to make cancer treatment shorter, safer and more effective. For engineers working on applied artificial intelligence, the core technical work sits in AI-driven, real-time motion synchronisation, alongside image-guided intensity-modulated radiation therapy, robotic control, megavoltage CT imaging and 3D kVCT imaging. The company's fields of activity span robotic radiosurgery, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
Two platforms anchor the product line. The CyberKnife System is a pioneering robotic radiosurgery device that delivers SRS and SBRT with true robotic precision and AI-driven, real-time motion synchronisation. The Radixact System is the latest generation TomoTherapy platform, integrating 3D kVCT and megavoltage CT imaging for advanced image-guided intensity-modulated radiation therapy.
Founded in 1990 by Dr. John R. Adler, Jr., a Stanford neurosurgeon, Accuray began commercial operations in 1992. It is headquartered in Madison, Wisconsin, and its systems are installed in approximately 50 countries. The company states a mission to expand the curative power of radiation therapy to improve as many lives as possible.
Its corporate social responsibility programme is organised around five pillars aligned with the United Nations 2030 Sustainable Development Goals: expanding access to healthcare, building strong communities, fostering inclusion and diversity, enhancing environmental sustainability, and maintaining trust and accountability.
